↓ Skip to main content

Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management

Overview of attention for article published in Current Rheumatology Reports, November 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
93 Mendeley
Title
Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management
Published in
Current Rheumatology Reports, November 2014
DOI 10.1007/s11926-014-0465-0
Pubmed ID
Authors

Elizabeth E. Bailey, David F. Fiorentino

Abstract

Amyopathic dermatomyositis can be a challenging diagnosis because patients lack traditional muscle findings. "Clinically amyopathic" dermatomyositis (CADM) accounts for the presence of subclinical muscle disease in some of these patients. These patients represent a substantial minority of dermatomyositis cases and have similar co-morbidities to "classic" dermatomyositis patients, including interstitial lung disease and malignancy. Clinically amyopathic dermatomyositis patients should not be considered as a distinct clinical entity from "classic" dermatomyositis, as they share antibody sub-types and associated co-morbidities, likely representing clinical spectrum of a common disease. It is essential for the clinician to be familiar with the clinical presentation of clinically amyopathic dermatomyositis, in order to facilitate early, accurate diagnosis and appropriate clinical management.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 92 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 13%
Other 11 12%
Student > Bachelor 10 11%
Student > Ph. D. Student 8 9%
Student > Doctoral Student 8 9%
Other 22 24%
Unknown 22 24%
Readers by discipline Count As %
Medicine and Dentistry 50 54%
Immunology and Microbiology 5 5%
Nursing and Health Professions 3 3%
Agricultural and Biological Sciences 2 2%
Psychology 2 2%
Other 5 5%
Unknown 26 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2019.
All research outputs
#13,747,876
of 23,306,612 outputs
Outputs from Current Rheumatology Reports
#432
of 720 outputs
Outputs of similar age
#127,350
of 263,600 outputs
Outputs of similar age from Current Rheumatology Reports
#10
of 12 outputs
Altmetric has tracked 23,306,612 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 720 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,600 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.